Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
- LOS ANGELES (AP) — Shohei Ohtani’s first walk-off hit for the Los Angeles Dodgers was also his first2024-05-21
BYU hires Suns assistant Kevin Young to replace Mark Pope, who left to coach Kentucky
PROVO, Utah (AP) — BYU hired Phoenix Suns associate head coach Kevin Young to replace Mark Pope, who2024-05-21The Biden administration recruits 15 states to help enforce airline consumer laws
The Biden administration is enlisting the help of officials in 15 states to enforce consumer-protect2024-05-21Advocates push for full Medicaid expansion as Mississippi legislators enter negotiations
JACKSON, Miss. (AP) — A coalition of advocates rallied for full Medicaid expansion Tuesday at the Mi2024-05-21Trump accepts a VP debate but wants it on Fox News. Harris has already said yes to CBS
NEW YORK (AP) — Donald Trump said Friday his campaign has accepted an invitation from Fox News for h2024-05-21Trump says New York judge won’t let him attend son’s graduation, no ruling has been made
CLAIM: New York Judge Juan M. Merchan told former President Donald Trump on the first day of his hus2024-05-21
atest comment